Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483691 · ClinicalTrials.gov registry record · NA
Trial of Home Visitation Among Infants With Failure To Thrive
A NA study of Failure to Thrive, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT00483691 is a NA study of Failure to Thrive that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 130 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00483691, a NA study of Failure to Thrive, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
1. Children in the home intervention group will have better growth (increase in weight and height) than children in the control group. 2. Children in the home intervention group will have better behavior than children in the control group. 3. Children in the home intervention group will have better academic performance than children in the control group.
Conditions Studied
Interventions
- BEHAVIORAL Home Visit
Study Locations (1)
Maryland
- University of Maryland Growth and Nutrition Clinic - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 1989-01 |
| Est. Completion | 1995-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00483691
The ClinicalTrials.gov registry entry for NCT00483691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Failure to Thrive appearing as the primary indexed condition, and to 1 intervention - of which Home Visit is the first listed.
NCT00483691 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00483691 about?
NCT00483691 is a clinical study titled "Trial of Home Visitation Among Infants With Failure To Thrive". 1. Children in the home intervention group will have better growth (increase in weight and height) than children in the control group. 2. Children in the home intervention group will have better behavior than children in the control group. 3. Children in the home intervention group will have better ...
What is the current status of trial NCT00483691?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 1989-01. Estimated completion is 1995-12.
What conditions does trial NCT00483691 study?
This clinical trial studies the following conditions: Failure to Thrive.
What interventions are being tested in trial NCT00483691?
The interventions under investigation include: Home Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00483691?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00483691 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Failure to Thrive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.